US Government Stake Speculation Intensifies IonQ Micron Anduril Emerge as Top Candidates Indian Bond Bull Market Poised for Pause but Not End Expert Suggests Oil Prices Reverse Course as Geopolitical Tensions Continue to Drive Market Volatility Standard Chartered to Cut Over 15 of Corporate Functions Roles Amid Efficiency Drive The Secretive and Lucrative World of Orchid Breeding A DecadeLong Investment Knightscope Secures Approximately 38 Million in New and Recurring Contracts Across Diverse Verticals INCR Q2 2023 Earnings EPS Surges Past Estimates as Profitability Strengthens CENT Q1 2026 Earnings Strong Profitability Despite Headwinds EPS Surges Past Estimates Design Therapeutics Inc DSGN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Gene Therapy Pipeline IPW Q3 2025 Earnings Narrow Loss Misses Estimates Stock Rises on Resilience VOXR Q1 2026 Earnings Massive EPS Surprise Drives Interest Yet Stock Falters Tucows Q1 2026 Earnings Net Loss Reported Shares Edge Lower PDX Holds Near Midpoint as PIMCO Dynamic Income Strategy Fund Maintains Stability BV Financial Inc BVFL Holds Near Support as Modest Gains Emerge Stantec Inc STN Pulls Back 1 as Support Levels Come Into Focus Tiptree Inc TIPT Gains Momentum Up 295 as Stock Approaches Key Resistance KimberlyClark KMB Gains 2 as Defensive Appeal Strengthens Amid Market Volatility GILT Q1 2026 Earnings Massive EPS Beat Driven by Strong Operational Performance MNOV Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances WERN Q1 2026 Earnings Unexpected Profit Surprises to the Upside as Werner Beats Expectations ExLabour Adviser Warns Schools Are Pipeline to Joblessness for UK Youth Urges Social Media Ban and Education Reform Vanguard Total International Stock Index Fund ETF VXUS Gains Attention as Graham Stephan Portfolio Pick US House Passes Bipartisan Bill to Boost Home Construction and Curb Corporate Buying Goldman Sachs Reportedly Selected to Lead SpaceX IPO in Potential Landmark Market Debut HUBG Q3 2025 Earnings EPS Misses Estimates by Narrow Margin Stock Edges Higher Kiniksa Pharmaceuticals KNSA Holds Near Flat as Stock Consolidates Near Key Levels